About AptaTargets
AptaTargets is a company based in Madrid (Spain) founded in 2014. AptaTargets has raised $2.98 million across 2 funding rounds from investors including EIT Health, Inveready and Caixa Capital Risc. AptaTargets offers products and services including ApTOLL. AptaTargets operates in a competitive market with competitors including Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others.
- Headquarter Madrid, Spain
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aptatargets.com
- Social LinkedIn
- Legal Name Aptatargets Sl
- Total Equity Funding$2.98M (USD)
in 2 rounds
- InvestorsEIT Health
& 2 more
Products & Services of AptaTargets
AptaTargets offers a comprehensive portfolio of products and services, including ApTOLL.
Blocks TLR4 activation to treat acute ischemic stroke and inflammation.
Funding Insights of AptaTargets
AptaTargets has successfully raised a total of $2.98M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.98M
- Total Rounds 2
- First Round $2.98M
(May 2017)
- Investors Count 3
All 2 funding rounds of AptaTargets with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | – | Grant | – | – | |
| May 2017 | $2.98M | Series A | – | – |
3 investors in total: 3 institutional.
Investors in AptaTargets
AptaTargets has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include EIT Health, Inveready and Caixa Capital Risc.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare startups are accelerated and incubated through specialized programs. | 2015 | eithealth.eu | Munich, Germany | |
Inveready is recognized as a leading Spanish financial services firm. | 2008 | inveready.com | San Sebastián, Spain | |
Venture capital investments are focused on healthcare and multiple sectors. | – | caixacapitalrisc.es | Barcelona, Spain |
Investor details for AptaTargets
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AptaTargets
15 people are tracked at AptaTargets (4 in leadership, 9 in board & advisors, 2 in team).
| Name | Role | Group |
|---|---|---|
David Saxner | Chief Business Officer | Leadership |
David Segarra | Co-Founder, Director & CEO | Leadership |
Marc Ribó | CMO | Leadership |
Maria Eugenia Zarabozo | Co-Founder, Director & CFO | Leadership |
Ignacio Lizasoain | Advisor | Board & advisors |
Mads Dalsgaard | Independent Board Member | Board & advisors |
Joaquín Casariego | Advisor | Board & advisors |
Marco Moreno | Advisor | Board & advisors |
Thomas Rupp | Advisor | Board & advisors |
Bernd Jilma | Advisor | Board & advisors |
Ian Cotgreave | Advisor | Board & advisors |
Víctor Manuel González | Advisor | Board & advisors |
Sara Secall | Director | Board & advisors |
Macarena Hernández | CSO | Team |
Marco Pugliese | Clinical Operations Manager | Team |
Complete people profiles for AptaTargets
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AptaTargets
3 dated milestones of AptaTargets across 4 years, from founding to its latest funding, stage changes and deals.
- Founded AptaTargets is founded.
- Funding First funding round of $3.0M.
- Funding Latest funding round, Grant,.
Competitors of AptaTargets
AptaTargets operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| grail.com | 2016 | Menlo Park, United States | $3.22B | 491 | Circulating tumor DNA is screened for early cancer detection. | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| strandls.com | 2000 | Bengaluru, India | $34.88M | 532 | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | |
| prenetics.com | 2009 | Hong Kong, China | $67.65M | – | Health risks are identified through online genetic and diagnostic testing. | |
| veracyte.com | 2008 | San Francisco, United States | $67.9M | 815 | Genomics-based diagnostic tests for cancer are developed. | |
| delfidiagnostics.com | 2019 | Baltimore, United States | $331.59M | – | Provider of DNA sequencing for cancer detection |
Detailed competitors of AptaTargets
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AptaTargets
The website of AptaTargets (aptatargets.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 3.5% vs previous month
Similar companies to AptaTargets
10 companies that operate in the same segment as AptaTargets (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AptaTargets
AptaTargets was founded in 2014 and raised its 1st funding round 3 years after it was founded.
AptaTargets is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
AptaTargets is a funded company, having raised a total of $2.98M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.98M, raised on May 2017.
AptaTargets is a provider of therapeutic solutions for ischemic diseases. It has developed ApTOLL product that consists of DNA aptamers with a specific 3D conformation. It will enable TL-4 antagonistic response for controlling the inflammatory response. The first application is the treatment of ischemic stroke. The candidate is currently completing preclinical studies.
AptaTargets's top competitors include Guardant Health, GRAIL and Strand Life Sciences.
AptaTargets offers ApTOLL.
AptaTargets has 3 investors. Key investors include EIT Health, Inveready, and Caixa Capital Risc.
AptaTargets operates through Aptatargets Sl.